Phytonadione Tablets — Class III drug recall D-0639-2021
Terminated recall by Bausch Health Companies, Inc., reported 2021-06-30, distributed nationwide. Failed Impurities/Degradation Specifications
| Recall number | D-0639-2021 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Bausch Health Companies, Inc., Bridgewater, NJ, United States |
| Recall initiated | 2021-06-08 |
| Classified | 2021-06-23 |
| Reported by FDA | 2021-06-30 |
| Terminated | 2023-02-16 |
| Distributed | Nationwide (US) |
| Quantity | 37,797 bottles |
| Reason classes | specification failure |
| NDC | 68682-0170-30 |
| Lot numbers | 19D013P, 20D099P |
| Expiration dates | 2021-07, 2022-10 |
Product
Phytonadione Tablets, 5 mg, 30-count ablets, Rx only, Manufactured for: Oceanside Pharmaceuticals, a division of Valeant Pharmaceuticals North America LLC, Bridgewater, NJ 08807 USA, NDC 68682-170-30
Reason for recall
Failed Impurities/Degradation Specifications
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0639-2021. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.